Abstract
Racemic 7-(phenylacetamido)-1-dethia-3-aza-1-carba-2-oxacephem 3 was synthesized and found to possess antibacterial activity against Staphylococcus aureus FDA 209P, Escherichia coli ATCC 39188, Pseudomonas aeruginosa 1101-75 and Klebsiella pneumoniae NCTC 418 as well as the beta-lactamase producing organisms E. coli A9675 and P. aeruginosa 18S-H and the methicillin-resistant organism S. aureus 95. Formation of the carbacephem 3 originated from the Barton photochemical reaction in the conversion of 8 to 10. Intramolecular cyclization of syn-oximino beta-lactam 10 afforded 7-azido-2-oxa-3-azacephem 11, which was reduced and acylated to 12. Enzymatic removal of the methyl group from 12 gave the target molecule 3.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Infective Agents / chemical synthesis*
-
Anti-Infective Agents / chemistry
-
Anti-Infective Agents / pharmacology*
-
Cell Division / drug effects
-
Cells, Cultured
-
Cephalosporins / chemical synthesis*
-
Cephalosporins / chemistry
-
Cephalosporins / pharmacology*
-
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / chemistry
-
Drug Resistance, Bacterial
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Escherichia coli / drug effects*
-
Escherichia coli / enzymology
-
Escherichia coli / genetics
-
Humans
-
Isomerism
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / genetics
-
Methicillin / pharmacology
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Pseudomonas aeruginosa / drug effects*
-
Pseudomonas aeruginosa / enzymology
-
Pseudomonas aeruginosa / genetics
-
Staphylococcus aureus / drug effects*
-
Staphylococcus aureus / enzymology
-
Staphylococcus aureus / genetics
-
beta-Lactamase Inhibitors
-
beta-Lactams / chemistry
-
beta-Lactams / pharmacology
Substances
-
1-dethia-3-aza-1-carba-2-oxacephem
-
Anti-Infective Agents
-
Cephalosporins
-
Enzyme Inhibitors
-
beta-Lactamase Inhibitors
-
beta-Lactams
-
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
-
Methicillin